selected publications
-
Leptomeningeal Metastases: New Opportunities in the Modern Era.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.
2022
Review
GET IT
Times cited: 6 - Characterization, isolation, and in vitro culture of leptomeningeal fibroblasts. Journal of neuroimmunology. 2021 Academic Article GET IT
-
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.
Cancer cell.
2021
Academic Article
GET IT
Times cited: 36 -
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
Journal of neuro-oncology.
2020
Academic Article
GET IT
Times cited: 32 -
Brain metastasis.
Nature reviews. Cancer.
2019
Review
GET IT
Times cited: 1 -
Tumour Dormancy and Reawakening: Opportunities and Challenges.
Trends in cancer.
2019
Review
GET IT
Times cited: 16 -
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Cell.
2017
Academic Article
GET IT
Times cited: 172 -
Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
Clinical breast cancer.
2016
Academic Article
GET IT
Times cited: 72 -
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer.
Nature.
2016
Academic Article
GET IT
Times cited: 531 -
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2016
Academic Article
GET IT
Times cited: 241 -
Molecular interactions in the development of brain metastases.
International journal of molecular sciences.
2013
Review
GET IT
Times cited: 10 -
Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis.
Cancer research.
2009
Academic Article
GET IT
Times cited: 127 -
Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site.
Cell.
2009
Academic Article
GET IT
Times cited: 212 - Targeted therapy in the treatment of malignant gliomas. OncoTargets and therapy. 2009 Academic Article GET IT
-
Emerging therapies for malignant glioma.
Expert review of anticancer therapy.
2007
Review
GET IT
Times cited: 13 -
Site-specific effects of peptide lipidation on beta-amyloid aggregation and cytotoxicity.
The Journal of biological chemistry.
2007
Academic Article
GET IT
Times cited: 23 -
Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
Biochemistry.
2006
Academic Article
GET IT
Times cited: 40 -
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
Cell.
2005
Academic Article
GET IT
Times cited: 714 -
Pollen recovery in atmospheric samples collected with the Rotorod Sampler over multiple-day periods such as weekends.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
1999
Academic Article
GET IT
Times cited: 9 -
A summary of the atmospheric surveys published in the United States allergy literature, 1966-1996.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
1999
Academic Article
GET IT
Times cited: 6